Publication:
Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease

dc.contributor.authorCortés, Jorge
dc.contributor.authorRodríguez, Diego
dc.contributor.authorValderrama, Martha
dc.contributor.authorRabagliati, Ricardo
dc.contributor.authorCapone, Domenico
dc.contributor.authorÁlvarez, Carlos
dc.contributor.authorVarón, Fabio
dc.contributor.authorNocua, Laura
dc.contributor.authorDiaz, Cándida
dc.contributor.authorEnciso, Leonardo
dc.contributor.authorCuervo, Sonia
dc.contributor.authorThompson, Luis
dc.contributor.authorCorzo, Dora
dc.contributor.authorCuéllar, Luis
dc.contributor.authorVergara, Erika
dc.contributor.authorRiera, Fernando
dc.contributor.authorCornejo, Patricia
dc.contributor.authorRojas, Rita
dc.contributor.authorGómez, Beatriz
dc.contributor.authorCelis, Adriana
dc.contributor.authorSandoval, José
dc.contributor.authorSarmiento, Mauricio
dc.contributor.authorOchoa, Diana
dc.contributor.authorNucci, Marcio
dc.date.accessioned2026-09-21T16:54:22Z
dc.date.available2026-09-21T16:54:22Z
dc.date.issued2025
dc.description.abstractAspergillosis is a disease caused by the filamentous fungus Aspergillus spp. with a spectrum of clinical presentation that includes invasive and noninvasive forms. The invasive clinical presentation of aspergillosis most frequently affects people with compromised immune systems. In patients with oncohematologic pathology, invasive lung aspergillosis is a significant opportunistic mycosis, because it occurs frequently and has a major impact on morbidity, mortality, and high costs. The global problem of antimicrobial resistance, to which improper use of antifungals contributes, has put Aspergilus spp. in the spotlight, so it is important to generate guidelines for guidance in the proper use of antifungals in the management of invasive lung aspergillosis, to obtain better clinical outcomes and promote rational use of antifungals. This guideline contains recommendations for diagnosing and treating invasive lung aspergillosis in patients with oncohematologic disease, based on evidence and defined through a participatory process of expert consensus, for the Latin American context.
dc.description.versionVersión Publicada
dc.identifier.citationCortés, J. A., Rodríguez-Lugo, D. A., Valderrama-Rios, M. C., Rabagliati, R., Capone, D., Álvarez-Moreno, C. A., Varón-Vega, F., Nocua-Báez, L. C., Diaz-Brochero, C., Enciso Olivera, L., Cuervo-Maldonado, S. I., Thompson, L., Corzo-León, D. E., Cuéllar, L. E., Vergara, E. P., Riera, F., Cornejo-Juárez, P., Rojas, R., Gómez, B. L., Celis-Ramírez, A. M., … Nucci, M. (2025). Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 29(2), 104517. https://doi.org/10.1016/j.bjid.2025.104517
dc.identifier.doihttps://doi.org/10.1016/j.bjid.2025.104517
dc.identifier.urihttps://hdl.handle.net/11447/11151
dc.language.isoen
dc.subjectAntifungal agents
dc.subjectHematologic neoplasms
dc.subjectInvasive pulmonary aspergillosis
dc.subjectLatin America
dc.titleEvidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease.pdf
Size:
2.21 MB
Format:
Adobe Portable Document Format
Description:
Texto Completo
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description: